Multiple binding modes of ibuprofen in human serum albumin identified by absolute binding free energy calculations

Human serum albumin possesses multiple binding sites and transports a wide range of ligands that include the anti-inflammatory drug ibuprofen. A complete map of the binding sites of ibuprofen in albumin is difficult to obtain in traditional experiments, because of the structural adaptability of this protein in accommodating small ligands. In this work, we provide a set of predictions covering the geometry, affinity of binding and protonation state for the pharmaceutically most active form (S-isomer) of ibuprofen to albumin, by using absolute binding free energy calculations in combination with classical molecular dynamics (MD) simulations and molecular docking. The most favorable binding modes correctly reproduce several experimentally identified binding locations, which include the two Sudlow's drug sites (DS2 and DS1) and the fatty acid binding sites 6 and 2 (FA6 and FA2). Previously unknown details of the binding conformations were revealed for some of them, and formerly undetected binding modes were found in other protein sites. The calculated binding affinities exhibit trends which seem to agree with the available experimental data, and drastically degrade when the ligand is modeled in a protonated (neutral) state, indicating that ibuprofen associates with albumin preferentially in its charged form. These findings provide a detailed description of the binding of ibuprofen, help to explain a wide range of results reported in the literature in the last decades, and demonstrate the possibility of using simulation methods to predict ligand binding to albumin.

[1]  R. Dror,et al.  Improved side-chain torsion potentials for the Amber ff99SB protein force field , 2010, Proteins.

[2]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[3]  Thomas Simonson,et al.  An Overview of Electrostatic Free Energy Computations for Solutions and Proteins. , 2014, Journal of chemical theory and computation.

[4]  B. Rizzuti,et al.  Stability of trans-resveratrol associated with transport proteins. , 2014, Journal of agricultural and food chemistry.

[5]  J. Seibold,et al.  Pharmacokinetics and Bioinversion of Ibuprofen Enantiomers in Humans , 1994, Pharmaceutical Research.

[6]  Peter M. Kasson,et al.  GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit , 2013, Bioinform..

[7]  T. Imai,et al.  Study of interaction of carprofen and its enantiomers with human serum albumin--II. Stereoselective site-to-site displacement of carprofen by ibuprofen. , 1993, Biochemical pharmacology.

[8]  Charles L. Brooks,et al.  Free energy screening of small ligands binding to an artificial protein cavity , 2000 .

[9]  Emil Alexov,et al.  Protonation and pK changes in protein–ligand binding , 2013, Quarterly Reviews of Biophysics.

[10]  R. Guzzi,et al.  Fatty acid binding into the highest affinity site of human serum albumin observed in molecular dynamics simulation. , 2015, Archives of biochemistry and biophysics.

[11]  T. R. C. Guizado,et al.  Analysis of the structure and dynamics of human serum albumin , 2014, Journal of Molecular Modeling.

[12]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[13]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[14]  Christopher I. Bayly,et al.  Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: II. Parameterization and validation , 2002, J. Comput. Chem..

[15]  David L. Mobley,et al.  Guidelines for the analysis of free energy calculations , 2015, Journal of Computer-Aided Molecular Design.

[16]  Dragana Mutavdžić Pavlović,et al.  Determination of p K a values of active pharmaceutical ingredients , 2007 .

[17]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[18]  O. Dangles,et al.  Flavonoid-serum albumin complexation: determination of binding constants and binding sites by fluorescence spectroscopy. , 2005, Biochimica et biophysica acta.

[19]  M. Rosales-Hernández,et al.  Exploration of human serum albumin binding sites by docking and molecular dynamics flexible ligand-protein interactions. , 2010, Biopolymers.

[20]  Stefan Boresch,et al.  Absolute Binding Free Energies: A Quantitative Approach for Their Calculation , 2003 .

[21]  Jennifer L. Knight,et al.  Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field. , 2015, Journal of the American Chemical Society.

[22]  G. Sudlow,et al.  The characterization of two specific drug binding sites on human serum albumin. , 1975, Molecular pharmacology.

[23]  S. Curry,et al.  Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. , 2000, Journal of molecular biology.

[24]  K. Dill,et al.  Blind prediction of charged ligand binding affinities in a model binding site. , 2013, Journal of molecular biology.

[25]  David L Mobley,et al.  The Confine-and-Release Method: Obtaining Correct Binding Free Energies in the Presence of Protein Conformational Change. , 2007, Journal of chemical theory and computation.

[26]  R. Zwanzig High‐Temperature Equation of State by a Perturbation Method. I. Nonpolar Gases , 1954 .

[27]  J. Simon,et al.  Interaction of ochratoxin A with human serum albumin. Binding sites localized by competitive interactions with the native protein and its recombinant fragments. , 2002, Chemico-biological interactions.

[28]  P. Deuflhard,et al.  Robust Perron cluster analysis in conformation dynamics , 2005 .

[29]  V. Trezza,et al.  Human serum albumin: from bench to bedside. , 2012, Molecular aspects of medicine.

[30]  P. Kollman,et al.  Automatic atom type and bond type perception in molecular mechanical calculations. , 2006, Journal of molecular graphics & modelling.

[31]  David L Mobley,et al.  Alchemical free energy methods for drug discovery: progress and challenges. , 2011, Current opinion in structural biology.

[32]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[33]  Michael R. Shirts,et al.  Statistically optimal analysis of samples from multiple equilibrium states. , 2008, The Journal of chemical physics.

[34]  J. Estelrich,et al.  Binding of non-steroidal anti-inflammatory drugs to human serum albumin , 1990 .

[35]  C. Riley,et al.  The Effect of Octanoic Acid on the Binding of the Enantiomers of Ibuprofen and Naproxen to Human Serum Albumin: A Chromatographic Implication , 2004, Pharmaceutical Research.

[36]  K. Dill,et al.  On the use of orientational restraints and symmetry corrections in alchemical free energy calculations. , 2006, The Journal of chemical physics.

[37]  T. Amisaki,et al.  Identification of high affinity fatty acid binding sites on human serum albumin by MM-PBSA method. , 2008, Biophysical journal.

[38]  C. Riley,et al.  A quantitative circular dichroic investigation of the binding of the enantiomers of ibuprofen and naproxen to human serum albumin. , 1997, Journal of pharmaceutical and biomedical analysis.

[39]  D. Mobley,et al.  Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration. , 2013, Journal of medicinal chemistry.

[40]  Y. Tsuda,et al.  Stereoselectivity and enantiomer-enantiomer interactions in the binding of ibuprofen to human serum albumin. , 1997, Chirality.

[41]  Dragana Mutavdžić Pavlović,et al.  Determination of pKa values of active pharmaceutical ingredients , 2007 .

[42]  P. Ascenzi,et al.  Effect of ibuprofen and warfarin on the allosteric properties of haem-human serum albumin. A spectroscopic study. , 2001, European journal of biochemistry.

[43]  P. Ascenzi,et al.  Ibuprofen binding to secondary sites allosterically modulates the spectroscopic and catalytic properties of human serum heme–albumin , 2011, The FEBS journal.

[44]  S. Curry,et al.  Structural basis of the drug-binding specificity of human serum albumin. , 2005, Journal of molecular biology.

[45]  P. Brick,et al.  Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites , 1998, Nature Structural Biology.

[46]  David L Mobley,et al.  Calculating the binding free energies of charged species based on explicit-solvent simulations employing lattice-sum methods: an accurate correction scheme for electrostatic finite-size effects. , 2013, The Journal of chemical physics.

[47]  Berk Hess,et al.  P-LINCS:  A Parallel Linear Constraint Solver for Molecular Simulation. , 2008, Journal of chemical theory and computation.

[48]  Chris Oostenbrink,et al.  Net charge changes in the calculation of relative ligand-binding free energies via classical atomistic molecular dynamics simulation , 2013, J. Comput. Chem..

[49]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[50]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[51]  Christophe Chipot,et al.  Standard binding free energies from computer simulations: What is the best strategy? , 2013, Journal of chemical theory and computation.

[52]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[53]  Emilio Gallicchio,et al.  Advances in all atom sampling methods for modeling protein-ligand binding affinities. , 2011, Current opinion in structural biology.

[54]  Julien Michel,et al.  Current and emerging opportunities for molecular simulations in structure-based drug design , 2014, Physical chemistry chemical physics : PCCP.

[55]  G. Elta,et al.  Stereoselective, competitive, and nonlinear plasma protein binding of ibuprofen enantiomers as determinedin vivo in healthy subjects , 1993, Journal of Pharmacokinetics and Biopharmaceutics.

[56]  K. Szlachta,et al.  Crystal structure of equine serum albumin in complex with cetirizine reveals a novel drug binding site. , 2016, Molecular immunology.

[57]  David L Mobley,et al.  Perspective: Alchemical free energy calculations for drug discovery. , 2012, The Journal of chemical physics.

[58]  Enzo Terreno,et al.  The extraordinary ligand binding properties of human serum albumin , 2005, IUBMB life.

[59]  J. Rose,et al.  Structural studies of several clinically important oncology drugs in complex with human serum albumin. , 2013, Biochimica et biophysica acta.

[60]  M. Otagiri,et al.  Species Differences of Serum Albumins: I. Drug Binding Sites , 1997, Pharmaceutical Research.

[61]  M. J. Crooks,et al.  Binding of nonsteroidal anti-inflammatory agents to proteins--I. Ibuprofen-serum albumin interaction. , 1979, Biochemical pharmacology.

[62]  Thomas Fox,et al.  Accuracy Assessment and Automation of Free Energy Calculations for Drug Design , 2014, J. Chem. Inf. Model..

[63]  D. S. Hage,et al.  Characterization of the protein binding of chiral drugs by high-performance affinity chromatography. Interactions of R- and S-ibuprofen with human serum albumin. , 1995, Journal of chromatography. A.